• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

Social Media

See the latest interactions from our social media


Dr. Michael Kirchengast will be attending the European Society of Cardiology Annual Conference #ESCCongress...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences, Inc. Reports Second Quarter 2015 Results and Provides Updated Guidance for 2015

  • $336.5 million of service revenue in the second quarter; 12% constant currency
    growth compared to the second quarter of 2014
  • $61.3 million of Adjusted EBITDA in the second...

PRA Health Sciences Launches New Initiative to Bolster Workforce

20 July 2015 Raleigh, NC – PRA Health Sciences (PRA) (NASDAQ: PRAH) is looking to hire new talent. To help attract potential employees from around the world, PRA, a leading global contract...

PRA Health Sciences Announces Time Change for Second Quarter 2015 Financial Results Conference Call

16 July 2015 Raleigh, NC – PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today that it has adjusted the start time for its second quarter 2015 financial results conference call on...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

CASE STUDY: PRA Feasibility Leads To Unique Enrollment Strategy

PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.


PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...

CASE STUDY: PRA Teamwork Demonstrates Vision

A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.


Find out what's happening next on PRA's event schedule

August 27 - August 29

The International Society for CNS Clinical Trials and Methodology (ISCTM) is a multi-disciplinary independent organization, devoted to promoting advances that address strategic clinical, regulatory, methodological and policy challenges that arise in the development and use of CNS therapeutic agents. This work is accomplished through partnership with persons in academia, industry, government, policy-making, and the public.

August 29 - September 2

The European Society of Cardiology (ESC) represents over 80,000 cardiology professionals, principally from across Europe and the Mediterranean basin, but also from the rest of the world. The ESC Congress is the largest and most influential cardiology event in the world. The ESC is also proud to hold, in conjunction with its constituent bodies,several subspecialty […]

September 2 - September 5

The 9th Congress of the European Pain Federation, EFIC® (EFIC 2015) will shine a spotlight on current trends and future developments in pain medicine. EFIC® has long been known as the European leader in the field of pain, and its European congresses harness the expertise and experience of 36 national Pain Chapters, representing more than […]

Read More >